Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
Keywords: درمان محرومیت از آندروژن; Testosterone; Prostate Cancer; Androgen Deprivation Therapy
مقالات ISI درمان محرومیت از آندروژن (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Management of osteoporosis in men on androgen deprivation therapy
Keywords: درمان محرومیت از آندروژن; Prostate cancer; Androgen deprivation therapy; Osteoporosis; Bisphosphonates; Fracture; SERMs; Denosumab
Hormonal therapy for cancer
Keywords: درمان محرومیت از آندروژن; androgen deprivation therapy; anti-androgens; aromatase inhibitors; breast cancer; hormone therapy; prostate cancer; selective oestrogen receptor modulators
Cáncer de próstata, terapia antiandrogénica y riesgo cardiovascular
Keywords: درمان محرومیت از آندروژن; Cáncer de próstata; Riesgo cardiovascular; Bloqueo androgénicoProstate cancer; Cardiovascular risk; Androgen deprivation therapy
Vertebral Fractures and the Misclassification of Osteoporosis in Men With Prostate Cancer
Keywords: درمان محرومیت از آندروژن; Androgen deprivation therapy; bone mineral density; osteoporosis; vertebral fractures; vertebral fracture assessment;
Dose Escalation for Prostate Cancer Radiotherapy: Predictors of Long-Term Biochemical Tumor Control and Distant Metastases–Free Survival Outcomes
Keywords: درمان محرومیت از آندروژن; External beam radiotherapy; Prostate cancer; Androgen deprivation therapy; PSA relapse–free survival; Dose escalation
Efficacy of a Second Line Luteinizing Hormone-Releasing Hormone Agonist After Advanced Prostate Cancer Biochemical Recurrence
Keywords: درمان محرومیت از آندروژن; prostate; prostatic neoplasms; prostate-specific antigen; leuprolide; goserelin; ADT; androgen deprivation therapy; CRPC; castrate resistant PC; GA; goserelin acetate; LA; leuprolide acetate; LHRH; luteinizing hormone-releasing hormone; PC; prostate cance
Prevalent and incident use of androgen deprivation therapy among men with prostate cancer in the United States
Keywords: درمان محرومیت از آندروژن; Prostate cancer; Androgen deprivation therapy; Practice patterns
Does Hormone Therapy Exacerbate the Adverse Effects of Radiotherapy in Men With Prostate Cancer? A Quality of Life Study
Keywords: درمان محرومیت از آندروژن; prostate; prostatic neoplasms; quality of life; radiotherapy; androgen antagonists; ADT; androgen deprivation therapy; AUASI; American Urological Association symptom index; BT; brachytherapy; EBRT; external beam RT; HRQOL; health related quality of life;
Cancer de la prostate à haut risque de progression. Article de revue du comité de cancérologie de l’association française d’urologie
Keywords: درمان محرومیت از آندروژن; Cancer de la prostate à haut risque; Radiothérapie; Hormonothérapie; Prostatectomie totale; Lymphadenectomie pelvienne étendue; Traitements combinésHigh-risk prostate cancer; Radiation therapy; Androgen deprivation therapy; Radical prostatectomy; Combined
The Timing and Extent of Androgen Deprivation Therapy for Prostate Cancer: Weighing the Clinical Evidence
Keywords: درمان محرومیت از آندروژن; Prostate cancer; Androgen deprivation therapy; Orchiectomy; Gonadotropin-releasing hormone agonist; Gonadotropin-releasing hormone antagonist;
Secondary Hormonal Therapy in Men With Castration-Resistant Prostate Cancer
Keywords: درمان محرومیت از آندروژن; Androgen deprivation therapy; Androgen resistance; Castration-resistant prostate cancer; Natural history; Secondary hormonal therapy
A Phase III Extension Trial With a 1-Arm Crossover From Leuprolide to Degarelix: Comparison of Gonadotropin-Releasing Hormone Agonist and Antagonist Effect on Prostate Cancer
Keywords: درمان محرومیت از آندروژن; prostate; prostatic neoplasms; progression-free survival; leuprolide; acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide; ADT; androgen deprivati
Promoting Wellness for Patients on Androgen Deprivation Therapy: Why Using Numerous Drugs for Drug Side Effects Should Not Be First-Line Treatment
Keywords: درمان محرومیت از آندروژن; Androgen deprivation therapy; Prostate cancer; Side effects; Toxicity;
Androgen Depletion Induces Senescence in Prostate Cancer Cells through Down-regulation of Skp2
Keywords: درمان محرومیت از آندروژن; ADT; androgen deprivation therapy; AIPC; androgen-independent prostate cancer; AR; androgen receptor; CS; charcoal-stripped fetal bovine serum; EMT; epithelial-to-mesenchymal transition; HP1β; heterochromatin protein 1β; IL-8; interleukin-8; IGFBP3; ins
Prostate Cancer Death of Men Treated With Initial Active Surveillance: Clinical and Biochemical Characteristics
Keywords: درمان محرومیت از آندروژن; prostatic neoplasms; mortality; prostate-specific antigen; ADT; androgen deprivation therapy; PSA; prostate specific antigen; PSA DT; prostate specific antigen doubling time;
Which α/β ratio and half-time of repair are useful for predicting outcomes in prostate cancer?
Keywords: درمان محرومیت از آندروژن; Prostate cancer; Radiotherapy; Radiobiology; α/β ratio; Androgen deprivation therapy
Robotic Assisted Laparoscopic Salvage Prostatectomy for Radiation Resistant Prostate Cancer
Keywords: درمان محرومیت از آندروژن; prostate; prostatic neoplasms; robotics; prostatectomy; salvage therapy; ADT; androgen deprivation therapy; BCR; biochemical recurrence; PLND; pelvic lymph node dissection; PSA; prostate specific antigen; RALP; robotic assisted laparoscopic radical prosta
Is Shared Decision Making in Prostate Cancer Restrained by Evidence-Based Medicine?
Keywords: درمان محرومیت از آندروژن; Androgen deprivation therapy; Prostate cancer; Screening; Prostate-specific antigen; Chemoprevention
Predicting Biochemical Recurrence-Free Survival for Patients With Positive Pelvic Lymph Nodes at Radical Prostatectomy
Keywords: درمان محرومیت از آندروژن; prostate; prostatic neoplasms; lymph node excision; neoplasm metastasis; prognosis; ADT; androgen deprivation therapy; BCR; biochemical recurrence; BPLND; bilateral PLND; LN; lymph node; PLND; pelvic LN dissection; PSA; prostate specific antigen; RP; radi
[11C]Choline Positron Emission Tomography/Computerized Tomography to Restage Prostate Cancer Cases With Biochemical Failure After Radical Prostatectomy and No Disease Evidence on Conventional Imaging
Keywords: درمان محرومیت از آندروژن; prostate; tomography, emission-computed; choline; prostate-specific antigen; prostatic neoplasms; ADT; androgen deprivation therapy; CT; computerized tomography; PCa; prostate cancer; PET; positron emission tomography; PSA; prostate specific antigen; PSAD
Correlates of Bother Following Treatment for Clinically Localized Prostate Cancer
Keywords: درمان محرومیت از آندروژن; prostatic neoplasms; quality of life; prostatectomy; radiotherapy; ADT; androgen deprivation therapy; AUASI; American Urological Association Symptom Index; EBRT; external beam radiation therapy; HRQOL; health related quality of life; MAX-PC; Memorial Anxi
Managing hot flushes in men after prostate cancer—A systematic review
Keywords: درمان محرومیت از آندروژن; Prostate cancer; Androgen deprivation therapy; Vasomotor symptoms; Hot flushes; Treatment
Factors impacting all-cause mortality in prostate cancer brachytherapy patients with or without androgen deprivation therapy
Keywords: درمان محرومیت از آندروژن; Prostate cancer; Testosterone; Overall survival; Androgen deprivation therapy;
Androgen deprivation therapy: a primer on concepts and therapeutic options
Keywords: درمان محرومیت از آندروژن; Androgen deprivation therapy; ADT; Prostate cancer; Treatment; Testosterone; Androgens;
Testosterone Measurement in Patients with Prostate Cancer
Keywords: درمان محرومیت از آندروژن; Androgen deprivation therapy; Androgen receptor; Luteinising hormone-releasing hormone agonist; Prostate cancer; Testosterone measurement
Potential Benefits of Intermittent Androgen Suppression Therapy in the Treatment of Prostate Cancer: A Systematic Review of the Literature
Keywords: درمان محرومیت از آندروژن; Androgen deprivation therapy; Antineoplastic agents, hormonal; Gonadotrophin-releasing hormone agonists; Intermittent androgen deprivation; Prostate cancer; Prostate-specific antigen; Quality of life; Survival; Testosterone
Cancers de la prostate cliniquement localisés à haut risque de progression
Keywords: درمان محرومیت از آندروژن; cancer de prostate; pronostic; hormonothérapie; radiothérapie; récidive; groupe à haut risque; prostate cancer; prognosis; androgen deprivation therapy; radiation therapy; recurrence; high-risk group;
Development of Carcinoid Tumour in Hormonally Treated Adenocarcinoma of the Prostate
Keywords: درمان محرومیت از آندروژن; Prostate; Adenocarcinoma; Hormone refractory; Carcinoid; Carcinoid syndrome; Neuroendocrine differentiation; Androgen deprivation therapy
Oncoforum Urology: Prostate Cancer 2008 at a Glance
Keywords: درمان محرومیت از آندروژن; Androgen deprivation therapy; Diagnosis; Hormone-refractory prostate cancer; Nomogram; Prostate cancer; Radical prostatectomy; Radiotherapy
A large proportion of patients with prostate cancer undergoing androgen deprivation therapy continue to die from non-cancer causes in the PSA era
Keywords: درمان محرومیت از آندروژن; ADT; androgen deprivation therapy; LHRH; luteinizing hormone-releasing hormone; MRC; Medical Research Council; PCa; prostate cancer; PSA; prostate specific antigen; VACURG; Veterans Administration Cooperative Urological Research Group; Androgen antagonist
Mechanisms mediating androgen receptor reactivation after castration
Keywords: درمان محرومیت از آندروژن; Androgen receptor; Prostate cancer; Testosterone; Androgen; Androgen deprivation therapy; AR antagonist
Improving Flexibility and Quality of Life for Your Patients: A Must?
Keywords: درمان محرومیت از آندروژن; Androgen deprivation therapy; Clinical practice; Communication; Prostate cancer; Tolerability; Quality of life
Pathological Effects of Prostate Cancer Correlate With Neuroendocrine Differentiation and PTEN Expression After Bicalutamide Monotherapy
Keywords: درمان محرومیت از آندروژن; prostatic neoplasms; treatment failure; bicalutamide; PTEN phosphohydrolase; epidermal growth factor; ADT; androgen deprivation therapy; BCR; biochemical recurrence; CgA; chromogranin A; ECE; extracapsular extension; HER; human epidermal receptor; IHC; im
Decreasing Use of Luteinizing Hormone-Releasing Hormone Agonists in the United States is Independent of Reimbursement Changes: A Medicare and Veterans Health Administration Claims Analysis
Keywords: درمان محرومیت از آندروژن; physician's practice patterns; prostatic neoplasms; antineoplastic agents; gonadotropin-releasing hormone; Medicare; ADT; androgen deprivation therapy; BESS; Part B Extract Summary System; CMS; Centers for Medicare and Medicaid Services; FDA; Food and Dru
Hormone Therapy for Prostate Cancer: Exploring Current Controversies
Keywords: درمان محرومیت از آندروژن; Androgen deprivation therapy; Hormone therapy; Intermittent hormone therapy; Luteinising hormone-releasing hormone agonist; Neoadjuvant therapy; Adjuvant therapy; Prostate cancer; Quality of life; Radical prostatectomy; Radiotherapy; Testosterone
Metabolic Syndrome and Prostate Cancer: A Review
Keywords: درمان محرومیت از آندروژن; Androgen deprivation therapy; insulin resistance; metabolic syndrome; prostate cancer;
Hormonal therapy for cancer
Keywords: درمان محرومیت از آندروژن; androgen deprivation therapy; anti-androgens; aromatase inhibitors; breast cancer; hormone therapy; prostate cancer; selective oestrogen receptor modulators;
Neoadjuvant and Adjuvant Hormone Therapy: How and When?
Keywords: درمان محرومیت از آندروژن; Adjuvant therapy; Androgen deprivation therapy; Hormone therapy; Neoadjuvant therapy; Prostate cancer; Prostatectomy; Radiotherapy
Androgen deprivation therapy for prostate cancer: Effects on hand function
Keywords: درمان محرومیت از آندروژن; Androgen deprivation therapy; Depression; Dexterity; Hand; Quality of life; Testosterone
Influence of Local Tumor Control on Distant Metastases and Cancer Related Mortality After External Beam Radiotherapy for Prostate Cancer
Keywords: درمان محرومیت از آندروژن; prostate; biopsy; mortality; radiotherapy; neoplasm metastasis; ADT; androgen deprivation therapy; DMFS; distant metastases-free survival; NAAD; neoadjuvant ADT; NCCN; National Comprehensive Cancer Network; NS; not significant; PSA; prostate specific anti
Body composition changes during androgen deprivation therapy for prostate cancer: A 2-year prospective study
Keywords: درمان محرومیت از آندروژن; Prostate cancer; Androgen deprivation therapy; Body composition; Dual-energy X-ray absorptiometry
Prostate Specific Antigen Kinetics in the Management of Prostate Cancer
Keywords: درمان محرومیت از آندروژن; prostatic neoplasms; prostate-specific antigen; prostatectomy; radiotherapy; survival; ADT; androgen deprivation therapy; AS; active surveillance; bRFS; biochemical RFS; CSS; cancer specific survival; DRE; digital rectal examination; NS; not statistically
Androgen deprivation therapy for precancerous lesions of the prostate
Keywords: درمان محرومیت از آندروژن; prostate cancer; adenocarcinoma; androgen deprivation therapy; high-grade PIN; finasteride
Androgen and prostate cancer: the role of primary androgen deprivation therapy in localized prostate cancer
Keywords: درمان محرومیت از آندروژن; Prostate cancer; Androgen deprivation therapy; Combined androgen blockade;
Metabolic Complications of Androgen Deprivation Therapy for Prostate Cancer
Keywords: درمان محرومیت از آندروژن; prostatic neoplasms; gonadotropin-releasing hormone agonists; cardiovascular diseases; diabetes mellitus; obesity; ADA; American Diabetes Association; ADT; androgen deprivation therapy; AHR; adjusted hazard ratio; BMI; body mass index; CaPSURE; Cancer of
The Effect of Androgen Deprivation Therapy on Periodontal Disease in Men With Prostate Cancer
Keywords: درمان محرومیت از آندروژن; prostate; prostatic neoplasms; osteoporosis; periodontal diseases; androgen antagonists; ADT; androgen deprivation therapy; BMD; bone mineral density;
Innovations and Challenges in Prostate Cancer: Summary Statement for the 6th Cambridge Conference
Keywords: درمان محرومیت از آندروژن; prostate; prostatic neoplasms; clinical conference [publication type]; ADT; androgen deprivation therapy; CRPC; castration resistant prostate cancer; EBRT; external beam radiation therapy; PSA; prostate specific antigen; PSADT; PSA doubling time; RP; radi
Monitoring of Prostate Cancer Patients: Guidelines and Current Practice
Keywords: درمان محرومیت از آندروژن; Androgen deprivation therapy; EAU guidelines; Hormone therapy; Intermittent treatment; Monitoring; Prostate cancer; Prostate-specific antigen; Side-effects; Testosterone
Additional Surgical Intervention after Radical Prostatectomy, Radiation Therapy, Androgen-Deprivation Therapy, or Watchful Waiting
Keywords: درمان محرومیت از آندروژن; Prostate cancer; Additional surgical intervention; Radical prostatectomy; Radiation therapy; Androgen deprivation therapy; Watchful waiting